Document:

<PAGE>

                                                                    EXHIBIT 10.8

                             MASTER LEASE AGREEMENT
                                     (QUASI)
                  dated as of NOVEMBER 18, 2003 ("AGREEMENT")

      THIS AGREEMENT is between GENERAL ELECTRIC CAPITAL CORPORATION (together
with its successors and assigns, if any, "LESSOR") and CYBERKINETICS, INC.
("LESSEE"). Lessor has an office at 401 Merritt 7 Suite 23, Norwalk, CT
06851-1177. Lessee is a corporation organized and existing under the laws of the
state of Delaware. Lessee's mailing address and chief place of business is 100
Foxborough Boulevard, Foxborough, MA 02035. This Agreement contains the general
terms that apply to the leasing of Equipment from Lessor to Lessee, Additional
terms that apply to the Equipment (term, rent, options, etc.) shall be contained
on a schedule ("SCHEDULE").

1. LEASING:

      (a) Lessor agrees to lease to Lessee, and Lessee agrees to lease from
Lessor, the equipment and other property ("EQUIPMENT") described in any Schedule
signed by both parties.

      (b) Lessor shall purchase Equipment from the manufacturer or supplier
("SUPPLIER") and lease it to Lessee if on or before the Last Delivery Date
(specified in the Schedule) Lessor receives (i) a Schedule for the Equipment,
(ii) evidence of insurance which complies with the requirements of Section 8,
and (iii) such other documents as Lessor may reasonably request. Each of the
documents required above must be in form and substance satisfactory to Lessor.
Lessor hereby appoints Lessee its agent for inspection and acceptance of the
Equipment from the Supplier. Once the Schedule is signed, the Lessee may not
cancel the Schedule.

2. TERM, RENT AND PAYMENT;

      (a) The rent payable for the Equipment and Lessee's right to use the
Equipment shall begin on the earlier of (i) the date when the Lessee signs the
Schedule and accepts the Equipment or (ii) when Lessee has accepted the
Equipment under a Certificate of Acceptance ("LEASE COMMENCEMENT DATE"). The
term of this Agreement shall be the period specified in the applicable Schedule.
The word "term" shall include all basic and any renewal terms.

      (b) Lessee shall pay rent to Lessor at its address stated above, except as
otherwise directed by Lessor. Rent payments shall be in the amount set forth in,
and due as stated in the applicable Schedule. If any Advance Rent (as stated in
the Schedule) is payable, it shall be due when the Lessee signs the Schedule.
Advance Rent shall be applied to the first rent payment and the balance, if any,
to the final rent payment(s) under such Schedule. In no event shall any Advance
Rent or any other rent payments be refunded to Lessee. If rent is not paid
within ten (10) days of its due date, Lessee agrees to pay a late charge of five
cents ($.05) per dollar on, and in addition to, the amount of such rent but not
exceeding the lawful maximum, if any.

3. TAXES:

      (a)If permitted by law, Lessee shall report and pay promptly all taxes,
fees and assessments due, imposed, assessed or levied against any Equipment (or
purchase, ownership, delivery, leasing, possession, use or operation thereof),
this Agreement (or any rents or receipts hereunder), any Schedule, Lessor or
Lessee by any governmental entity or taxing authority during or related to the
term of this Agreement, including, without limitation, all license and
registration fees, and all sales, use, personal property, excise, gross
receipts, franchise, stamp or other taxes, imposts, duties and charges, together
with any penalties, fines or interest thereon (collectively "TAXES"). Lessee
shall have no liability for Taxes imposed by the United States of America or any
State or political subdivision thereof which are on or measured by the net
income of Lessor. Lessee shall promptly reimburse Lessor (on an after tax basis)
for any Taxes charged to or assessed against Lessor. Lessee shall send Lessor a
copy of each report or return and evidence of Lessees payment of Taxes upon
request.

      (b)Lessee's obligations, and Lessor's rights and privileges, contained in
this Section 3 shall survive the expiration or other termination of this
Agreement.

4. REPORTS:

      (a) If any tax or other lien shall attach to any Equipment, Lessee will
notify Lessor in writing, within ten (10) days after Lessee becomes aware of the
tax or lien. The notice shall include the full particulars of the tax or lien
and the location of such Equipment on the date of the notice.

<PAGE>

      (b)Lessee will deliver to Lessor Lessees complete financial statements,
certified by a recognized firm of certified public accountants, within one
hundred fifty (150) days of the close of each fiscal year of Lessee. If Lessor
requests, Lessee will deliver to Lessor copies of Lessee's quarterly financial
report certified by the chief financial officer of Lessee, within ninety (90)
days of the close of each fiscal quarter of Lessee. Lessee will deliver to
Lessor ail Forms 10-K and 10Q, if any, filed with the Securities and Exchange
Commission within thirty (30) days after the date on which they are filed.

      (c)Lessor may inspect any Equipment during normal business hours after
giving Lessee reasonable prior notice.

      (d)Lessee will keep the Equipment at the Equipment Location (specified in
the applicable Schedule) and will give Lessor prior written notice of any
relocation of Equipment. If Lessor requests, Lessee will promptly notify Lessor
in writing of the location of any Equipment,

      (e)If any Equipment is lost or damaged (where the estimated repair costs
would exceed the greater of ten percent (10%) of the original Equipment cost or
ten thousand and 00/100 dollars ($10,000)), or is otherwise involved in an
accident causing personal injury or property damage, Lessee will promptly and
fully report the event to Lessor in writing.

      (f)Lessee will furnish a certificate of an authorized officer of Lessee
stating that he has reviewed the activities of Lessee and that, to the best of
his knowledge, there exists no default or event which with notice or lapse of
time (or both) would become such a default within thirty (30) days after any
request by Lessor.

      (g)Lessee will promptly notify Lessor of any change in Lessee's state of
incorporation or organization.

5. DELIVERY, USE AND OPERATION:

      (a) All Equipment shall be shipped directly from the Supplier to Lessee.

      (b) Lessee agrees that the Equipment will be used by Lessee solely in the
conduct of its business and in a manner complying with all applicable laws,
regulations and insurance policies, and Lessee shall not discontinue use of the
Equipment.

      (c) Lessee will not move any equipment from the location specified on the
Schedule, without the prior written consent of Lessor.

      (d) Lessee will keep the Equipment free and clear of all liens and
encumbrances other than those which result from acts of Lessor.

      (e) Lessor shall not disturb Lessees quiet enjoyment of the Equipment
during the term of the Agreement unless a default has occurred and is continuing
under this Agreement.

6. MAINTENANCE:

      (a) Lessee will, at its sole expense, maintain each unit of Equipment in
good operating order and repair, normal wear and tear excepted. The Lessee shall
also maintain the Equipment in accordance with manufacturers recommendations.
Lessee shall make all alterations or modifications required to comply with any
applicable law, rule or regulation during the term of this Agreement. If Lessor
requests, Lessee shall affix plates, tags or other identifying labels showing
ownership thereof by Lessee and Lessor's security interest therein. The tags or
labels shall be placed in a prominent position on each unit of Equipment.

      (b) Lessee will not attach or install anything on the Equipment that will
impair the originally intended function or use of such Equipment without the
prior written consent of Lessor. All additions, parts, supplies, accessories,
and equipment ("ADDITIONS") furnished or attached to any Equipment that are not
readily removable shall become subject to the lien of Lessor. All Additions
shall be made only in compliance with applicable law. Lessee will not attach or
install any Equipment to or in any other personal or real property without the
prior written consent of Lessor.

7. STIPULATED LOSS VALUE: If for any reason any unit of Equipment becomes worn
out, lost, stolen, destroyed, irreparably damaged or unusable ("CASUALTY
OCCURRENCES") Lessee shall promptly and fully notify Lessor in writing. Lessee
shall pay Lessor the sum of (i) the Stipulated Loss Value (see Schedule) of the
affected unit determined as of the rent payment date prior to the Casualty
Occurrence; and (ii) all rent and other amounts which are then due under this
Agreement on the Payment Date (defined below) for the affected unit. The Payment
Date shall be the next rent payment date after the Casualty Occurrence. Upon
payment of all sums due hereunder, the term of this lease as to such unit shall
terminate.

<PAGE>

8. INSURANCE:

      (a) Lessee shall bear the entire risk of any loss, theft, damage to, or
destruction of, any unit of Equipment from any cause whatsoever from the time
the Equipment is shipped to Lessee,

      (b) Lessee agrees, at its own expense, to keep all Equipment insured for
such amounts and against such hazards as Lessor may reasonably require. All such
policies shall be with companies, and on terms, reasonably satisfactory to
Lessor. The insurance shall include coverage for damage to or loss of the
Equipment, liability for personal injuries, death or property damage. Lessor
shall be named as additional insured with a loss payable clause in favor of
Lessor, as its interest may appear, irrespective of any breach of warranty or
other act or omission of Lessee. The insurance shall provide for liability
coverage in an amount equal to at least ONE MILLION U.S, DOLLARS ($1,000,000.00)
total liability per occurrence, unless otherwise stated in any Schedule. The
casualty/property damage coverage shall be in an amount equal to the higher of
the Stipulated Loss value or the full replacement cost of the Equipment. No
insurance shall be subject to any co-insurance clause. The insurance policies
shall provide that the insurance may not be altered or canceled by the insurer
until after thirty (30) days written notice to Lessor. Lessee agrees to deliver
to Lessor evidence of insurance reasonably satisfactory to Lessor.

      (c) Lessee hereby appoints Lessor as Lessee's attorney-in-fact to make
proof of loss and claim for insurance, and to make adjustments with insurers and
to receive payment of and execute or endorse all documents, checks or drafts in
connection with insurance payments. Lessor shall not act as Lessees attorney-in-
fact unless Lessee is in default. Lessee shall pay any reasonable expenses of
Lessor in adjusting or collecting insurance. Lessee will not make adjustments
with insurers except with respect to claims for damage to any unit of Equipment
where the repair costs are less than the lesser of ten percent (10%) of the
original Equipment cost or ten thousand and 00/100 dollars ($10,000). Lessor
may, at its option, apply proceeds of insurance, in whole or in part, to (i)
repair or replace Equipment or any portion thereof, or (ii) satisfy any
obligation of Lessee to Lessor under this Agreement.

9. RETURN OF EQUIPMENT:

      (a) At the expiration or termination of this Agreement or any Schedule,
Lessee shall perform any testing and repairs required to place the units of
Equipment in the same condition and appearance as when received by Lessee
(reasonable wear and tear excepted) and in good working order for the original
intended purpose of the Equipment, If required the units of Equipment shall be
deinstalled, disassembled and crated by an authorized manufacturer's
representative or such other service person as is reasonably satisfactory to
Lessor. Lessee shall remove installed markings that are not necessary for the
operation, maintenance or repair of the Equipment. All Equipment will be
cleaned, cosmetically acceptable, and in such condition as to be immediately
installed into use in a similar environment for which the Equipment was
originally intended to be used. All waste material and fluid must be removed
from the Equipment and disposed of in accordance with then current waste
disposal laws. Lessee shall return the units of Equipment to a location within
the continental United States as Lessor shall direct. Lessee shall obtain and
pay for a policy of transit insurance for the redelivery period in an amount
equal to the replacement value of the Equipment. The transit insurance must name
Lessor as the loss payee. The Lessee shall pay for all costs to comply with this
section (a).

      (b) Until Lessee has fully complied with the requirements of Section 9(a)
above, Lessee's rent payment obligation and all other obligations under this
Agreement shall continue from month to month notwithstanding any expiration or
termination of the lease term. Lessor may terminate the Lessee's right to use
the Equipment upon ten (10) days notice to Lessee.

      (c) Lessee shall provide to Lessor a detailed inventory of all components
of the Equipment including model and serial numbers. Lessee shall also provide
an up-to-date copy of all other documentation pertaining to the Equipment. All
service manuals, blue prints, process flow diagrams, operating manuals,
inventory and maintenance records shall be given to Lessor at least ninety (90)
days and not more than one hundred twenty (120) days prior to lease termination.

      (d) Lessee shall make the Equipment available for on-site operational
inspections by potential purchasers at least one hundred twenty (120) days prior
to and continuing up to lease termination. Lessor shall provide Lessee with
reasonable notice prior to any inspection. Lessee shall provide personnel, power
and other requirements necessary to demonstrate electrical, hydraulic and
mechanical systems for each item of Equipment.

10. DEFAULT AND REMEDIES:

      (a) Lessor may in writing declare this Agreement in default if: (i) Lessee
breaches its obligation to pay rent or any other sum when due and fails to cure
the breach within ten (10) days; (ii) Lessee breaches any of its insurance
obligations under Section 8; (iii) Lessee breaches any of its other obligations
and fails to cure that breach within thirty (30) days after written notice from
Lessor; (iv) any representation or warranty made by Lessee in connection with
this Agreement shall be false or misleading in any material respect; (v) Lessee
or any guarantor or other obligor for the Lessee's obligations hereunder
("GUARANTOR") becomes insolvent or ceases to do business as a going concern;
(vi) any Equipment is illegally used; (vii) if Lessee or any Guarantor is a
natural person, any death or incompetency of Lessee or such Guarantor; (viii) a
petition is filed by or against Lessee or any Guarantor under any bankruptcy or
insolvency laws and in the event of an involuntary petition, the petition is not
dismissed within forty-five (45) days of the filing date; or (ix) Lessee
defaults under any other material

<PAGE>

obligation for (A) borrowed money, (B) the deferred purchase price of property,
or (C) payments due under lease agreements. The default declaration shall apply
to all Schedules unless specifically excepted by Lessor.

      (b) After a default, at the request of Lessor, Lessee shall comply with
the provisions of Section 9(a). Lessee hereby authorizes Lessor to peacefully
enter any premises where any Equipment may be and take possession of the
Equipment. Lessee shall immediately pay to Lessor without further demand as
liquidated damages for loss of a bargain and not as a penalty, the Stipulated
Loss Value of the Equipment. (calculated as of the rent payment date prior to
the declaration of default), and all rents and other sums then due under this
Agreement and all Schedules. Lessor may terminate this Agreement as to any or
all of the Equipment. A termination shall occur only upon written notice by
Lessor to Lessee and only as to the units of Equipment specified in any such
notice. Lessor may, but shall not be required to, sell Equipment at private or
public sale, in bulk or in parcels, with or without notice, and without having
the Equipment present at the place of sale. Lessor may also, but shall not be
required to, lease, otherwise dispose of or keep idle all or part of the
Equipment. Lessor may use Lessee's premises for a reasonable period of time for
any or all of the purposes stated above without liability for rent, costs,
damages or otherwise. The proceeds of sale, lease or other disposition, if any,
shall be applied in the following order of priorities: (i) to pay all of
Lessor's costs, charges and expenses incurred in taking, removing, holding,
repairing and selling, leasing or otherwise disposing of Equipment; then, (ii)
to the extent not previously paid by Lessee, to pay Lessor all sums due from
Lessee under this Agreement; then (iii) to reimburse to Lessee any sums
previously paid by Lessee as liquidated damages; and then (iv) to Lessee, if
there exists any surplus. Lessee shall immediately pay any deficiency in (i) and
(ii) above.

      (c) The foregoing remedies are cumulative, and any or all thereof may be
exercised instead of or in addition to each other or any remedies at law, in
equity, or under statute. Lessee waives notice of sale or other disposition (and
the time and place thereof), and the manner and place of any advertising. Lessee
shall pay Lessor's actual attorney's fees incurred in connection with the
enforcement, assertion, defense or preservation of Lessor's rights and remedies
under this Agreement, or if prohibited by law, such lesser sum as may be
permitted. Waiver of any default shall not be a waiver of any other or
subsequent default.

      (d) Any default under the terms of this or any other agreement between
Lessor and Lessee may be declared by Lessor a default under this and any such
other agreement.

11. ASSIGNMENT: LESSEE SHALL NOT SELL, TRANSFER, ASSIGN, ENCUMBER OR SUBLET ANY
EQUIPMENT OR THE INTEREST OF LESSEE IN THE EQUIPMENT WITHOUT THE PRIOR WRITTEN
CONSENT OF LESSOR. Lessor may, without the consent of Lessee, assign this
Agreement, any Schedule or the right to enter into a Schedule. Lessee agrees
that if Lessee receives written notice of an assignment from Lessor, Lessee will
pay all rent and all other amounts payable under any assigned Schedule to such
assignee or as instructed by Lessor. Lessee also agrees to confirm in writing
receipt of the notice of assignment as may be reasonably requested by assignee.
Lessee hereby waives and agrees not to assert against any such assignee any
defense, set-off, recoupment claim or counterclaim which Lessee has or may at
any time have against Lessor for any reason whatsoever.

12. NET LEASE: Lessee is unconditionally obligated to pay all rent and other
amounts due for the entire lease term no matter what happens, even if the
Equipment is damaged or destroyed, if it is defective or if Lessee no longer can
use it. Lessee is not entitled to reduce or set-off against rent or other
amounts due to Lessor or to anyone to whom Lessor assigns this Agreement or any
Schedule whether Lessees claim arises out of this Agreement, any Schedule, any
statement by Lessor, Lessors liability or any manufacturers liability, strict
liability, negligence or otherwise.

13. INDEMNIFICATION:

      (a) Lessee hereby agrees to indemnify Lessor, its agents, employees,
successors and assigns (on an after tax basis) from and against any and all
losses, damages, penalties, injuries, claims, actions and suits, including legal
expenses, of whatsoever kind and nature arising out of or relating to the
Equipment or this Agreement, except to the extent the losses, damages,
penalties, injuries, claims, actions, suits or expenses result from Lessors
gross negligence or willful misconduct ("CLAIMS"). This indemnity shall include,
but is not limited to, Lessor's strict liability in tort and Claims, arising out
of (i) the selection, manufacture, purchase, acceptance or rejection of
Equipment, the ownership of Equipment during the term of this Agreement, and the
delivery, lease, possession, maintenance, uses, condition, return or operation
of Equipment (including, without limitation, latent and other defects, whether
or not discoverable by Lessor or Lessee and any claim for patent, trademark or
copyright infringement or environmental damage) or (ii) the condition of
Equipment sold or disposed of after use by Lessee, any sublessee or employees of
Lessee. Lessee shall, upon request, defend any actions based on, or arising out
of, any of the foregoing subject to prompt notice of any matter as to which
indemnification may be sought and the opportunity to defend the same with
counsel of Lessee's selection at Lessee's cost.

      (b) All of Lessor's rights, privileges and indemnities contained in this
Section 13 shall survive the expiration or other termination of this Agreement.
The rights, privileges and indemnities contained herein are expressly made for
the benefit of, and shall be enforceable by Lessor, its successors and assigns.

<PAGE>

14. DISCLAIMER: LESSEE ACKNOWLEDGES THAT IT HAS SELECTED THE EQUIPMENT WITHOUT
ANY ASSISTANCE FROM LESSOR, ITS AGENTS OR EMPLOYEES. LESSOR DOES NOT MAKE, HAS
NOT MADE, NOR SHALL BE DEEMED TO MAKE OR HAVE MADE, ANY WARRANTY OR
REPRESENTATION, EITHER EXPRESS OR IMPLIED, WRITTEN OR ORAL, WITH RESPECT TO THE
EQUIPMENT LEASED UNDER THIS AGREEMENT OR ANY COMPONENT THEREOF, INCLUDING,
WITHOUT LIMITATION, ANY WARRANTY AS TO DESIGN, COMPLIANCE WITH SPECIFICATIONS,
QUALITY OF MATERIALS OR WORKMANSHIP, MERCHANTABILITY, FITNESS FOR ANY PURPOSE,
USE OR OPERATION, SAFETY, PATENT, TRADEMARK OR COPYRIGHT INFRINGEMENT, OR TITLE.
All such risks, as between Lessor and Lessee, are to be borne by Lessee. Without
limiting the foregoing, Lessor shall have no responsibility or liability to
Lessee or any other person with respect to any of the following: (i) any
liability, loss or damage caused or alleged to be caused directly or indirectly
by any Equipment, any inadequacy thereof, any deficiency or defect (latent or
otherwise) of the Equipment, or any other circumstance in connection with the
Equipment; (ii) the use, operation or performance of any Equipment or any risks
relating to it; (iii) any interruption of service, loss of business or
anticipated profits or consequential damages; or (iv) the delivery, operation,
servicing, maintenance, repair, improvement or replacement of any Equipment. If,
and so long as, no default exists under this Agreement, Lessee shall be, and
hereby is, authorized during the term of this Agreement to assert and enforce,
whatever claims and rights Lessor may have against any Supplier of the Equipment
at Lessee's sole cost and expense, in the name of and for the account of Lessor
and/or Lessee, as their interests may appear.

15. REPRESENTATIONS AND WARRANTIES OF LESSEE: Lessee makes each of the following
representations and warranties to Lessor on the date hereof and on the date of
execution of each Schedule:

      (a) Lessee has adequate power and capacity to enter into, and perform
under, this Agreement and all related documents (together, the "DOCUMENTS").
Lessee is duly qualified to do business wherever necessary to carry on its
present business and operations, including the jurisdiction(s) where the
Equipment is or is to be located.

      (b) The Documents have been duly authorized, executed and delivered by
Lessee and constitute valid, legal and binding agreements, enforceable in
accordance with their terms, except to the extent that the enforcement of
remedies may be limited under applicable bankruptcy and insolvency laws.

      (c) No approval, consent or withholding of objections is required from
any governmental authority or entity with respect to the entry into or
performance by Lessee of the Documents except such as have already been
obtained.

      (d) The entry into and performance by Lessee of the Documents will not:
(i) violate any judgment, order, law or regulation applicable to Lessee or any
provision of Lessee's Certificate of Incorporation or bylaws; or (ii) result in
any breach of, constitute a default under or result in the creation of any lien,
charge, security interest or other encumbrance upon any Equipment pursuant to
any indenture, mortgage, deed of trust, bank loan or credit agreement or other
instrument (other than this Agreement) to which Lessee is a party.

      (e) There are no suits or proceedings pending or threatened in court or
before any commission, board or other administrative agency against or affecting
Lessee, which if decided against Lessee will have a material adverse effect on
the ability of Lessee to fulfill its obligations under this Agreement.

      (f) The Equipment accepted under any Certificate of Acceptance is and will
remain tangible personal property.

      (g) Each financial statement delivered to Lessor has been prepared in
accordance with generally accepted accounting principles consistently applied.
Since the date of the most recent financial statement, there has been no
material adverse change.

      (h) Lessee's exact legal name is as set forth in the first sentence of
this Agreement and Lessee is and will be at all times validly existing and in
good standing under the laws of the State of its incorporation (specified in the
first sentence of this Agreement).

      (i) The Equipment will at all times be used for commercial or business
purposes.

      (j) Lessee is and will remain in full compliance with all laws and
regulations applicable to it including, without limitation, (i) ensuring that no
person who owns a controlling interest in or otherwise controls Lessee is or
shall be (Y) listed on the Specially Designated Nationals and Blocked Person
List maintained by the Office of Foreign Assets Control ("OFAC"), Department of
the Treasury, and/or any other similar lists maintained by OFAC pursuant to any
authorizing statute, Executive Order or regulation or (Z) a person designated
under Section 1(b), (c) or (d) of Executive Order No. 13224 (September 23,
2001), any related enabling legislation or any other similar Executive Orders,
and (ii) compliance with all applicable Bank Secrecy Act ("BSA") laws,
regulations and government guidance on BSA compliance and on the prevention and
detection of money laundering violations.

<PAGE>

16. OWNERSHIP FOR TAX PURPOSES, GRANT OF SECURITY INTEREST; USURY SAVINGS:

      (a) For income tax purposes, the parties hereto agree that it is their
mutual intention that Lessee shall be considered the owner of the Equipment.
Accordingly, Lessor agrees (i) to treat Lessee as the owner of the Equipment on
its federal income tax return, (ii) not to take actions or positions
inconsistent with such treatment on or with respect to its federal income tax
return, and (iii) not to claim any tax benefits available to an owner of the
Equipment on or with respect to its federal income tax return. The foregoing
undertakings by Lessor shall not be violated by Lessor's taking a tax position
inconsistent with the foregoing sentence to the extent such a position is
required by law or is taken through inadvertence so long as such inadvertent tax
position is reversed by Lessor promptly upon its discovery. Lessor shall in no
event be liable to Lessee if Lessee fails to secure any of the tax benefits
available to the owner of the Equipment.

      (b) Lessee hereby grants to Lessor a first security interest in the
Equipment, together with all additions, attachments, accessions, accessories
and accessions thereto whether or not furnished by the Supplier of the Equipment
and any and all substitutions, replacements or exchanges therefor, and any and
all insurance and/or other proceeds of the property in and against which a
security interest is granted hereunder. This security interest is given to
secure the payment and performance of all debts, obligations and liabilities of
any kind whatsoever of Lessee to Lessor, now existing or arising in the future
under this Agreement or any Schedules attached hereto, and any renewals,
extensions and modifications of such debts, obligations and liabilities.

      (c) It is the intention of the parties hereto to comply with any
applicable usury laws to the extent that any Schedule is determined to be
subject to such laws; accordingly, it is agreed that, notwithstanding any
provision to the contrary in any Schedule or this Agreement, in no event shall
any Schedule require the payment or permit the collection of interest in excess
of the maximum amount permitted by applicable law. If any such excess interest
is contracted for, charged or received under any Schedule or this Agreement, or
in the event that all of the principal balance shall be prepaid, so that under
any of such circumstances the amount of interest contracted for, charged or
received under any Schedule or this Agreement shall exceed the maximum amount of
interest permitted by applicable law, then in such event (i) the provisions of
this paragraph shall govern and control, (ii) neither Lessee nor any other
person or entity now or hereafter liable for the payment hereof shall be
obligated to pay the amount of such interest to the extent that it is in excess
of the maximum amount of interest permitted by applicable law, (iii) any such
excess which may have been collected shall be either applied as a credit against
the then unpaid principal balance or refunded to Lessee, at the option of the
Lessor, and (iv) the effective rate of interest shall be automatically reduced
to the maximum lawful contract rate allowed under applicable law as now or
hereafter construed by the courts having jurisdiction thereof. It is further
agreed that without limitation of the foregoing, all calculations of the rate of
interest contracted for, charged or received under any Schedule or this
Agreement which are made for the purpose of determining whether such rate
exceeds the maximum lawful contract rate, shall be made, to the extent permitted
by applicable law, by amortizing, prorating, allocating and spreading in equal
parts during the period of the full stated term of the indebtedness evidenced
hereby, all interest at any time contracted for, charged or received from Lessee
or otherwise by Lessor in connection with such indebtedness; provided, however,
that if any applicable state law is amended or the law of the United States of
America preempts any applicable state law, so that it becomes lawful for Lessor
to receive a greater interest per annum rate than is presently allowed, the
Lessee agrees that, on the effective date of such amendment or preemption, as
the case may be, the lawful maximum hereunder shall be increased to the maximum
interest per annum rate allowed by the amended state law or the law of the
United States of America.

17. EARLY TERMINATION:

      (a) On or after the First Termination Date (specified in the applicable
Schedule), Lessee may, so long as no default exists hereunder, terminate this
Agreement as to all (but not less than all) of the Equipment on such Schedule as
of a rent payment date ("TERMINATION DATE"). Lessee must give Lessor at least
ninety (90) days prior written notice of the termination.

      (b) Lessee shall, and Lessor may, solicit cash bids for the Equipment on
an AS IS, WHERE IS BASIS without recourse to or warranty from Lessor, express or
implied ("AS IS BASIS"). Prior to the Termination Date, Lessee shall (i) certify
to Lessor any bids received by Lessee and (ii) pay to Lessor (A) the Termination
Value (calculated as of the rent due on the Termination Date) for the Equipment,
and (B) all rent and other sums due and unpaid as of the Termination Date.

      (c) If all amounts due hereunder have been paid on the Termination Date,
Lessor shall (i) sell the Equipment on an AS IS BASIS for cash to the highest
bidder and (ii) refund the proceeds of such sale (net of any related expenses)
to Lessee up to the amount of the Termination Value. If such sale is not
consummated, no termination shall occur and Lessor shall refund the Termination
Value (less any expenses incurred by lessor) to Lessee.

      (d) Notwithstanding the foregoing, Lessor may elect by written notice, at
any time prior to the Termination Date, not to sell the Equipment. In that
event, on the Termination Date Lessee shall (i) return the Equipment (in
accordance with Section 9) and (ii) pay to Lessor all amounts required under
Section 17(b) less the amount of the highest bid certified by Lessee to Lessor.

<PAGE>

18. EARLY PURCHASE OPTION:

      (a) Lessee may purchase on an AS IS BASIS all (but not less than all) of
the Equipment on any Schedule on any Rent Payment Date after the First
Termination Date specified in the applicable Schedule but prior to the last Rent
Payment Date of such Schedule (the "EARLY PURCHASE DATE"), for a price equal to
(i) the Termination Value (calculated as of the Early Purchase Date) for the
Equipment, and (ii) all rent and other sums due and unpaid as of the Early
Purchase Date (the "EARLY OPTION PRICE"), plus all applicable sales taxes.
Lessee must notify Lessor of its intent to purchase the Equipment in writing at
least thirty (30) days, but not more than two hundred seventy (270) days, prior
to the Early Purchase Date. If Lessee is in default or if the Schedule or this
Agreement has already been terminated, Lessee may not purchase the Equipment.
(The purchase option granted by this subsection shall be referred to herein as
the "EARLY PURCHASE OPTION").

      (b) If Lessee exercises its Early Purchase Option, then on the Early
Purchase Date, Lessee shall pay to Lessor any rent and other sums due and unpaid
on the Early Purchase Date and Lessee shall pay the Early Option Price, plus all
applicable sales taxes, to Lessor in cash.

19. END OF LEASE PURCHASE OPTION: Lessee may, at lease expiration, purchase all
(but not less than all) of the Equipment on any Schedule on an AS IS BASIS for
cash equal to the amount indicated on such Schedule (the "OPTION PAYMENT"), plus
all applicable sales taxes. The Option Payment, plus all applicable sales taxes,
shall be due and payable in immediately available funds on the expiration date
of such Schedule. Lessee must notify Lessor of its intent to purchase the
Equipment in writing at least one hundred eighty (180) days prior to the
expiration date of the Schedule. If Lessee is in default, or if the Schedule or
this Agreement has already been terminated, Lessee may not purchase the
Equipment.

20. MISCELLANEOUS:

      (a) LESSEE AND LESSOR UNCONDITIONALLY WAIVE THEIR RIGHTS TO A JURY TRIAL
OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF THIS AGREEMENT, ANY
OF THE RELATED DOCUMENTS, ANY DEALINGS BETWEEN LESSEE AND LESSOR RELATING TO THE
SUBJECT MATTER OF THIS TRANSACTION OR ANY RELATED TRANSACTIONS, AND/OR THE
RELATIONSHIP THAT IS BEING ESTABLISHED BETWEEN LESSEE AND LESSOR. THE SCOPE OF
THIS WAIVER IS INTENDED TO BE ALL ENCOMPASSING OF ANY AND ALL DISPUTES THAT MAY
BE FILED IN ANY COURT. THIS WAIVER IS IRREVOCABLE. THIS WAIVER MAY NOT BE
MODIFIED EITHER ORALLY OR IN WRITING. THE WAIVER ALSO SHALL APPLY TO ANY
SUBSEQUENT AMENDMENTS, RENEWALS, SUPPLEMENTS OR MODIFICATIONS TO THIS AGREEMENT,
ANY RELATED DOCUMENTS, OR TO ANY OTHER DOCUMENTS OR AGREEMENTS RELATING TO THIS
TRANSACTION OR ANY RELATED TRANSACTION. THIS AGREEMENT MAY BE FILED AS A WRITTEN
CONSENT TO A TRIAL BY THE COURT.

      (b) Any cancellation or termination by Lessor of this Agreement, any
Schedule, supplement or amendment hereto, or the lease of any Equipment
hereunder shall not release Lessee from any then outstanding obligations to
Lessor hereunder. All Equipment shall at all times remain personal property even
though it may be attached to real property. The Equipment shall not become part
of any other property by reason of any installation in, or attachment to, other
real or personal property.

      (c) Time is of the essence of this Agreement. Lessor's failure at any time
to require strict performance by Lessee of any of the provisions hereof shall
not waive or diminish Lessor's right at any other time to demand strict
compliance with this Agreement. Lessee agrees, upon Lessor's request, to
execute, or otherwise authenticate, any document, record or instrument necessary
or expedient for filing, recording or perfecting the interest of Lessor or to
carry out the intent of this Agreement. In addition, Lessee hereby authorizes
Lessor to file a financing statement and amendments thereto describing the
Equipment described in any and all Schedules now and hereafter executed pursuant
hereto and adding any other collateral described therein and containing any
other information required by the applicable Uniform Commercial Code. Lessee
irrevocably grants to Lessor the power to sign Lessee's name and generally to
act on behalf of Lessee to execute and file financing statements and other
documents pertaining to any or all of the Equipment. Lessee hereby ratifies its
prior authorization for Lessor to file financing statements and amendments
thereto describing the Equipment and containing any other information required
by any applicable law (including without limitation the Uniform Commercial Code)
if filed prior to the date hereof. All notices required to be given hereunder
shall be deemed adequately given if sent by registered or certified mail to the
addressee at its address stated herein, or at such other place as such addressee
may have specified in writing. This Agreement and any Schedule and Annexes
thereto constitute the entire agreement of the parties with respect to the
subject matter hereof. NO VARIATION OR MODIFICATION OF THIS AGREEMENT OR ANY
WAIVER OF ANY OF ITS PROVISIONS OR CONDITIONS, SHALL BE VALID UNLESS IN WRITING
AND SIGNED BY AN AUTHORIZED REPRESENTATIVE OF THE PARTIES HERETO

      (d) If Lessee does not comply with any provision of this Agreement, Lessor
shall have the right, but shall not be obligated, to effect such compliance, in
whole or in part. All reasonable amounts spent and obligations incurred or
assumed by Lessor in effecting such compliance shall constitute additional rent
due to Lessor. Lessee shall pay the additional rent within five days after the
date Lessor sends notice to Lessee requesting payment. Lessor's effecting such
compliance shall not be a waiver of Lessee's default.

<PAGE>

      (e) Any rent or other amount not paid to Lessor when due shall bear
interest, from the due date until paid, at the lesser of eighteen percent (18%)
per annum or the maximum rate allowed by law. Any provisions in this Agreement
and any Schedule that are in conflict with any statute, law or applicable rule
shall be deemed omitted, modified or altered to conform thereto.

      (f) Lessee hereby irrevocably authorizes Lessor to adjust the Capitalized
Lessor's Cost up or down by no more than ten percent [10%] within each Schedule
to account for equipment change orders, equipment returns, invoicing errors, and
similar matters. Lessee acknowledges and agrees that the rent shall be adjusted
as a result of the change in the Capitalized Lessor's Cost Lessor shall send
Lessee a written notice stating the final Capitalized Lessor's Cost, if it has
changed.

      (g) THIS AGREEMENT AND THE RIGHTS AND OBLIGATIONS OF THE PARTIES HEREUNDER
SHALL IN ALL RESPECTS BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH, THE
INTERNAL LAWS OF THE STATE OF CONNECTICUT (WITHOUT REGARD TO THE CONFLICT OF
LAWS PRINCIPLES OF SUCH STATE), INCLUDING ALL MATTERS OF CONSTRUCTION, VALIDITY
AND PERFORMANCE, REGARDLESS OF THE LOCATION OF THE EQUIPMENT.

      (h) Any cancellation or termination by Lessor, pursuant to the provisions
of this Agreement, any Schedule, supplement or amendment hereto, of the lease of
any Equipment hereunder, shall not release Lessee from any then outstanding
obligations to Lessor hereunder.

      (i) To the extent that any Schedule would constitute chattel paper, as
such term is defined in the Uniform Commercial Code as in effect in any
applicable jurisdiction, no security interest therein may be created through the
transfer or possession of this Agreement in and of itself without the transfer
or possession of the original of a Schedule executed pursuant to this Agreement
and incorporating this Agreement by reference; and no security interest in this
Agreement and a Schedule may be created by the transfer or possession of any
counterpart of the Schedule other than the original thereof, which shall be
identified as the document marked Original and all other counterparts shall be
marked Duplicate.

      (j) Each party hereto agrees to keep confidential, the terms and
provisions of the Documents and the transactions contemplated hereby and thereby
(collectively, the "TRANSACTIONS"). Notwithstanding the foregoing, the
obligations of confidentiality contained herein, as they relate to the
Transactions, shall not apply to the federal tax structure or federal tax
treatment of the Transactions, and each party hereto (and any employee,
representative, or agent of any party hereto) may disclose to any and all
persons, without limitation of any kind, the federal tax structure and federal
tax treatment of the Transactions. The preceding sentence is intended to cause
each Transaction to be treated as not having been offered under conditions of
confidentiality for purposes of Section I,6011-4(b)(3) (or any successor
provision) of the Treasury Regulations promulgated under Section 6011 of the
Internal Revenue Code of 1986, as amended, and shall be construed in a manner
consistent with such purpose. In addition, each party hereto acknowledges that
it has no proprietary or exclusive rights to the federal tax structure of the
Transactions or any federal tax matter or federal tax idea related to the
Transactions.

      IN WITNESS WHEREOF, Lessee and Lessor have caused this Agreement to be
executed by their duly authorized representatives as of the date first above
written.

LESSOR:                                     LESSEE:

GENERAL ELECTRIC CAPITAL CORPORATION        CYBERKINETICS, INC.

By: /s/John Edel                            By: /s/Timothy R. Surgenor
    -------------------------                   --------------------------

Name: JOHN EDEL                             Name: TIMOTHY R. SURGENOR

Title: SVP                                  Title: PRESIDENT & CEO

<PAGE>

                                    AMENDMENT

      THIS AMENDMENT is made as of the 18th day of November, 2003, between
General Electric Capital Corporation ("Lessor") and Cyberkinetics, Inc.
("Lessee") in connection with that certain Master Lease Agreement, dated as of
November 18, 2003 ("Agreement"). The terms of this Amendment are hereby
incorporated into the Agreement as though fully set forth therein. Section
references below refer to the section numbers of the Agreement. The Agreement is
hereby amended as follows:

      10. DEFAULT AND REMEDIES:

      Subsection (a) is hereby amended with the following:

            "(a) Lessor may in writing declare this Agreement in default if: (i)
            Lessee breaches its obligation to pay rent or any other sum when due
            and fails to cure the breach within ten (10) days; (ii) Lessee
            breaches any of its insurance obligations under Section 9; (iii)
            Lessee breaches any of its other obligations and fails to cure that
            breach within thirty (30) days after written notice from Lessor;
            (iv) any representation or warranty made by Lessee in connection
            with this Agreement shall be false or misleading in any material
            respect; (v) Lessee or any guarantor or other obligor for the
            Lessee's obligations hereunder ("GUARANTOR") becomes insolvent or
            ceases to do business as a going concern; (vi) any Equipment is
            illegally used; (vii) if Lessee or any Guarantor is a natural
            person, any death or incompetency of Lessee or such Guarantor;
            (viii) a petition is filed by or against Lessee or any Guarantor
            under any bankruptcy or insolvency laws and in the event of an
            involuntary petition, the petition is not dismissed within
            forty-five (45) days of the filing date; (ix) Lessee defaults under
            any other material obligation for (A) borrowed money, (B) the
            deferred purchase price of property, or (C) payments due under lease
            agreements; (x) there is any dissolution, termination of existence,
            merger, or consolidation of Lessee or any Guarantor; or (xi) there
            is a material adverse change in the Lessee's financial condition as
            determined solely by the Lessor in it's reasonable discretion. The
            default declaration shall apply to all Schedules unless specifically
            excepted by Lessor."

      TERMS USED, BUT NOT OTHERWISE DEFINED HEREIN SHALL HAVE THE MEANINGS GIVEN
TO THEM IN THE AGREEMENT. EXCEPT AS EXPRESSLY AMENDED HEREBY, THE AGREEMENT
SHALL REMAIN IN FULL FORCE AND EFFECT. IF THERE IS ANY CONFLICT BETWEEN THE
PROVISIONS OF THE AGREEMENT AND THIS AMENDMENT, THEN THIS AMENDMENT SHALL
CONTROL.

      IN WITNESS WHEREOF, the parties hereto have executed this Amendment
simultaneously with the Agreement by signature of their respective authorized
representative set forth below.

GENERAL ELECTRIC CAPITAL CORPORATION        CYBERKINETICS, INC.

By: /s/John Edel                             By: /s/Timothy R. Surgenor
    -------------------------                    --------------------------

Name: JOHN EDEL                              Name: TIMOTHY R. SURGENOR

Title: SVP                                   Title: PRESIDENT & CEO

<PAGE>

                          EQUIPMENT CONCENTRATION RIDER

CYBERKINETICS, INC. ("Customer"), on or before October 31, 2004, shall cause the
composition and mix of Equipment financed after November 18, 2003 under the
Master Lease Agreement dated as of November 18, 2003 between Customer and
General Electric Capital Corporation to conform to and meet the following
concentration requirements (hereinafter "Concentration Requirements") for each
class of Equipment (hereinafter "Equipment Class") as identified and set forth
below. Customer herein represents and warrants that it shall maintain each such
Equipment Class and its respective Concentration Requirement from and after such
above referenced date and continuing thereafter to the end of the term:

      EQUIPMENT CLASS                             CONCENTRATION REQUIREMENT

      Laboratory & Manufacturing                        Minimum of 50%
      Equipment:

      Tenant Improvements, Software, & Other
      "Soft" Costs such as tax, freight,
      installation, etc. related to the
      acquisition of the Lab, Manufacturing,
      Computer Hardware, and General Office
      Equipment:                                        Maximum of 30%

Accepted and Agreed:

Cyberkinetic, Inc.

By: /s/ Timothy R. Surgenor
    ---------------------------

Title: PRESIDENT & CEO

Date: 12/8/03<PAGE>

                                                                    EXHIBIT 10.9

                            CLINICAL STUDY AGREEMENT
                              CYBERKINETICS, INC.

                 FEASIBILITY CLINICAL STUDY OF THE CYBERKINETICS
                     BRAINGATE(TM) NEURAL INTERFACE SYSTEM

This document sets forth an Agreement ("Agreement") among Cyberkinetics, Inc.
("Cyberkinetics"), Jon Mukand, M.D., Ph.D. (the "Principal Investigator or PI")
and Sargent Rehabilitation Center ("Institution") regarding the performance of
certain services by the Institution for a Cyberkinetics clinical study as
described in the Protocol entitled DD-CP-0002, "Feasibility Study of the
BrainGate(TM) Neural Interface System Feasibility Study in Patients Unable to
Use Their Hands" (the "Study") a copy of which is attached as Attachment "A" and
incorporated herein by reference, in accordance with the protocol set forth
therein (the "Study Protocol"). The Effective Date of the Agreement is December
22, 2003.

WHEREAS, Cyberkinetics is desirous of conducting clinical research (hereinafter
the "Research") at the Institution.

WHEREAS, the Institution is an educational, research and/or health care
institution and is desirous of conducting the Research in order to advance its
educational and scientific clinical research missions and promote the health of
the public; the parties agree as follows:

1. PERFORMANCE

      (a) The PI and Institution agrees to use their best efforts to perform the
Study in accordance with the instructions, timing and directions set forth in
the Study Protocol, and all applicable laws and regulations, as well as any
amendments to the Study Protocol that are mutually agreed to and documented by
the parties. The Principal Investigator will use his/her reasonable best efforts
to perform all the services described herein, or incidental to those described
herein, at the Institution in accordance with the highest standards of medical
and clinical research practice. The Study will be conducted in accordance with
the Study Protocol and all applicable laws and regulations, as well as any
amendments to that protocol mutually agreed to and documented by the parties
hereto. In the event of a conflict between this Agreement and the Study Protocol
the terms of this Agreement will govern. The parties acknowledge that this is a
multi-center study with overall enrollment and implant limits, so Principal
Investigator agrees to coordinate patient enrollments with Cyberkinetics such
that these limits are not exceeded. The PI and Institution agree to ensure that
an Institutional Review Board ("IRB") that complies with the requirements of 21
C.F.R. Part 56 will be responsible for the initial and continuing review and
approval of the Study. The parties also agree to promptly report to the IRB and
each other all changes in the research activity and all unanticipated problems
involving risk to human subjects or others. Additionally the parties agree to
not make any changes in the study without IRB approval except where necessary to
eliminate apparent immediate hazards to human subject.

(b) If Jon Mukand, M.D., Ph.D. ceases to serve as Principal Investigator for any
reason, Principal Investigator and Institution shall promptly notify
Cyberkinetics, and Institution and Cyberkinetics shall use reasonable good faith
efforts to identify a mutually acceptable

Confidential                                                            1/7/2004

                                     Page 1
<PAGE>

replacement within thirty (30) days. If a suitable replacement Principal
Investigator cannot be identified within the thirty day period, Cyberkinetics
shall have the right to terminate this Agreement as provided in Section 12.
Institution will make reasonable efforts to complete the study for patients
that are already enrolled or work with Cyberkinetics to transfer these patients
to another Study site.

(c) Performance of the Study under this Agreement shall commence not later than
March, 2004, unless appropriate IRB approval(s) are not obtained by March, 2004,
in which case performance shall commence immediately after obtaining such
approvals. Regarding the performance hereunder, time is of the essence. In case
of delayed performance, this Agreement may at Cyberkinetics' request, be
extended for subsequent periods until the Study is completed.

(d) In full payment and compensation for the performance under this Agreement,
Cyberkinetics will cover all direct and indirect costs of the Study as agreed to
on the separate budget in Attachment B. Invoices will be generated by the PI and
sent to Cyberkinetics for payment. An initial payment of will be made to cover
IRB and start-up costs. Subsequently, the PI will invoice Cyberkinetics as
patients complete the visits required by the Study Protocol. Payments will be
made by Cyberkinetics within 30 days of receipt of invoice.

2. TIME FRAME

The parties anticipate that enrollment and implantation of up to five subjects
will be completed within four (4) months of the Effective Date of this
Agreement or final Institution Review Board ("IRB") and Food and Drug
Administration ("FDA") Investigational Device Exemption ("IDE") approval,
whichever occurs later.

3. INVENTIONS; WARRANTIES

(a) All rights, title and interest in and to Cyberkinetics' BrainGate(TM) and
related accessories (the "Device") shall remain the exclusive property of
Cyberkinetics; the Institution and the Principal Investigator shall acquire no
rights of any kind whatsoever with respect to the Device, the know-how incident
thereto and any patent applications and patents related thereto as a result of
performance under this Agreement or otherwise. Institution and the Principal
Investigator agree that all inventions, discoveries and technology relating to
the Device, whether patentable or not, conceived or reduced to practice by the
Principal Investigator, solely or jointly with others as a result of work done
under this Agreement ("Inventions") shall be and remain, at all times, the sole
and exclusive property of Cyberkinetics. Institution shall promptly report in
writing any Invention to Cyberkinetics, and shall ensure that at all times the
Principal Investigator and any investigator participating in the Study that
could be deemed to be an "inventor" of any such Inventions shall be subject to a
valid and binding agreement assigning all of his or her rights to any such
Inventions (without cost to Cyberkinetics) to the Institution (which rights are
hereby assigned to Cyberkinetics pursuant to this Section 3). Any and all acts
reasonably necessary to assist Cyberkinetics in perfecting its right to any and
all Inventions and any patent applications or patents related thereto shall be
performed by the Institution, and/or

Confidential                                                            1/7/2004

                                     Page 2
<PAGE>

Principal Investigator at Cyberkinetics' expense. Without limiting the
foregoing, the Institution shall be entitled to a royalty-free license to use,
for research purposes only, inventions that are developed, discovered or reduced
to practice in the performance of the Study which are owned by Cyberkinetics.
The Institution and the Principal Investigator certify by the execution of this
Agreement, that to their knowledge they have not entered, and will not enter,
into any contractual agreement or relationship which would in any way conflict
with or compromise Cyberkinetics' proprietary interest in, or rights to, any
inventions, discoveries or technology existing at the time of the execution of
this Agreement or directly arising out of or materially related to the
performance hereunder.

(b) The Institution warrants that it or the Principal Investigator will obtain
from all individuals subject to the Study an adequate and properly executed
informed consent. The Institution also warrants that the informed consent form
complies with all applicable federal and state laws and regulations. The
Institute further warrants that it and the Principal Investigator will comply
with all federal and state laws and regulations concerning record keeping,
project conduct, receipt and disposition of product, and obtaining of adequate
informed consent from individuals subject to treatment in the Study, and that
it, the Principal Investigator, and any subinvestigators will comply with the
confidentiality requirements established in Section 9 of this Agreement.

4. DATA

Except as provided in Section 8 of this Agreement, all data and results
generated or produced in the Study except patient and hospital records,
including all information required on case report forms in the Protocol ("Data")
shall be the sole exclusive property of Cyberkinetics. The investigator shall
prepare and submit to Cyberkinetics all original case report forms as provided
in the Protocol. Investigator shall have the right to retain copies of all data
and results arising from its participation in the Study solely for the purposes
permitted by this Agreement. The Investigator may use such Data for research and
education purposes in accordance with this Agreement, but, except as set forth
in Section 8, will not transfer any such Data collected under the Protocol to
any third party without the prior written permission of Cyberkinetics. All Data
collected under the Protocol shall be delivered to Cyberkinetics in a timely
manner throughout the performance of this Study, as provided in the Protocol,
and no later than ten (10) working days after the termination of this Agreement
or on such date as Cyberkinetics otherwise requests delivery of the Data.

5. RECORD KEEPING/RETENTION

Investigator agrees to maintain complete and up-to-date Study records during the
Study including Case Report Forms and the Study Site file, which includes all
Study-related correspondence. Investigator agrees to sign a statement in each
patient's Case Report Form attesting that the data contained therein are an
accurate accounting of the treatment, care, and events surrounding the patient's
involvement in the Study.

Investigator will retain all records for this Study for the last to expire of:

(a) Two (2) years after the FDA or other national regulatory body approves the
regulatory application for product clearance;

Confidential                                                            1/7/2004

                                     Page 3
<PAGE>

(b) Two (2) years following the termination or withdrawal of the regulatory
agency exemption (e.g., Investigational Device Exemption (IDE) application)
under which the Study was conducted;

(c) As defined by local, state and federal law and regulations; or

(d) In any event no later than ten (10) years after the conclusion of the Study.

To avoid any possible errors, Investigator will contact Cyberkinetics prior to
the destruction of records or in the event of accidental loss or destruction of
any Study records.

The PI shall make periodic reports to Cyberkinetics, including a final written
report on the performance of the Study, upon its completion and shall promptly
respond to Cyberkinetics' reasonable inquiries regarding the status of the
Study. The PI agrees to promptly report to Cyberkinetics adverse experiences
that occur in the course of the Study.

6. CYBERKINETICS RIGHT OF REASONABLE INSPECTION

Personnel from Cyberkinetics (or its representatives) may call on Investigator
periodically at mutually convenient times to monitor and/or audit the Study and
answer procedural questions. Investigator agrees, as defined in the Protocol, to
make all Study records and Study participants' medical records available for
comparison and/or copying if requested by Cyberkinetics (or its representatives
subject to compliance with patient privacy and confidentiality rights).
Investigator also agrees to cooperate with representatives of the U.S. FDA or
any other regulatory agency in the event of an inspection of this Study, and
will provide the regulatory agency representative access to the above-described
records. Institution agrees to notify Cyberkinetics immediately upon the
commencement of an inspection by FDA or any other government authority
concerning the Study and to provide continual communication regarding the
progress of any inspection.

7. USE OF NAME/PUBLICITY

No party shall, without the prior written consent of the affected party, use in
advertising, publicity, press release, or otherwise, the name, trademark, logo,
symbol, or other image of the affected party. Except as permitted in Section 8,
the Investigator and Institution (which shall include its employees, agents and
representatives) shall not issue or disseminate any press release or statement,
nor initiate any communication of information regarding this Study, written or
oral, to the communications media or any third party without the prior written
consent of Cyberkinetics.

8. SCIENTIFIC PRESENTATIONS AND PUBLICATIONS

The Investigator and/or Institution may present or publish the Data in
appropriate scientific journals or other professional publications/forums. It is
the intent of this study to be a multi-center study and presentation and
publication of the pooled, multi-center results will occur before any individual
site results or additional analyses are presented or published. Authorship will
be determined by the Investigators at each study site together with
Cyberkinetics using appropriate standards for research authorship. It is
anticipated that authorship for multi-center presentations and publications will
include the scientific inventor(s) of the BrainGate devices, Investigators and
Co-Investigators by site in order of highest to lowest number patients implanted
and implanting surgeon(s).

Confidential                                                       1/7/2004

                                     Page 4
<PAGE>

Investigator shall submit to Cyberkinetics for its review, a copy of any
proposed abstract for presentation or manuscript resulting from the Study at
least sixty (60) days prior to the estimated date of submission for presentation
or publication, and if no response is received within, sixty (60) days of the
date submitted to Cyberkinetics, it will be conclusively presumed that the
presentation or publication may proceed without delay. If Cyberkinetics
determines that the proposed presentation or publication contains patentable
subject matter which requires protection, Cyberkinetics may require the delay of
presentation or publication for a period of time not to exceed sixty (60) days
for the purpose of filing patent applications. At the end of the sixty (60) day
period the authors shall be free in their sole discretion to publish the results
of the Study.

In all presentations and publications, credit shall be given to Cyberkinetics
for its sponsorship of the Study and the supply of the Device under the Study.

9. CONFIDENTIALITY

For the purposes of this Agreement, "Confidential Information" means all
information provided by or on behalf of Cyberkinetics to the Investigator in
connection with the Study by the Investigator in connection with the Study,
whether written, graphic or oral, except the following: (i) Information that is
now or subsequently becomes public without breach of this Agreement; (ii)
Information known by the Investigator, as evidenced by written records, prior to
the date of this Agreement; (iii) Information that the Investigator received
from a third party not under any obligation to keep such information
confidential; and (iv) was developed independently by the Institution.

Except for publication of the Data pursuant to Section 8 hereof, the
Investigator agrees to maintain all Confidential Information in confidence and
not to use or disclose for a period not to exceed three (3) years any
Confidential Information to any third party without the express written consent
of Cyberkinetics. The Investigator shall disclose Confidential Information only
to those employees who require such information for the purposes of this
Agreement and who are bound by a like obligation of confidentiality.

Upon the completion of the Study, the Institution and the Principal Investigator
agree to return all copies or embodiments of Confidential Information upon the
written request of Cyberkinetics.

10. LIABILITY/INSURANCE/WARRANTY DISCLAIMER

Cyberkinetics will indemnify, hold harmless and defend the Principal
Investigator and Institution (including the Principal Investigator, any
employees of the Institution and the Institution's, agents and representatives,
the "Indemnified Parties") from and against any claims, liabilities, costs,
damages, expenses and reasonable attorneys' fees (collectively, "Losses")
relating to or resulting from the use of the Device in the Study (and not
resulting from the performance of, or complications arising from, standard
clinical care procedures); provided that Cyberkinetics shall have no obligation
to indemnify, hold harmless and defend the Indemnified Parties under this
Section 10 for any claim unless (1) the Principal Investigator and the
Institution, its agents, servants and employees are shown to have adhered to and
complied with all specifications and directions of the Protocol for the Study,
all applicable FDA and other regulatory requirements

Confidential                                                       1/7/2004

                                     Page 5
<PAGE>

and all Cyberkinetics written instructions concerning the administration and use
of the Device in the Study Protocol; (2) Cyberkinetics is promptly notified in
writing of such claim or suit; and (3) Cyberkinetics has full control of the
defense, including settlement of the claim or suit and receives the full
cooperation of the Institution and Principal Investigator, its agents and
employees. Notwithstanding the foregoing, Cyberkinetics shall have no liability
to Indemnified Parties, or any obligation to indemnify hereunder, if the Losses
have resulted from negligence, recklessness or willful malfeasance of any of the
Indemnified Parties.

Institution shall, to the extent permitted by law, be responsible for its own
acts in conducting the Study, limited solely and exclusively to the extent such
acts are judicially determined by a court of last resort to have arisen out of,
or result from: (i) the negligence recklessness or willful malfeasance on the
part of the Institution; or (ii) the failure of the Institution to (1) comply
with any applicable FDA or other regulatory requirements, or (2) adhere to the
terms of the Protocol or Cyberkinetics written instructions concerning the
administration and use of the Device involved in the Study. The parties agree
that this is only a statement setting forth the limited responsibility of the
Institution solely for its own acts of judicially determined negligence,
recklessness, or willful malfeasance, and is not and shall not be construed as
any contractual or other obligation to indemnify Cyberkinetics or any third
party.

Cyberkinetics will maintain, during the term of this Agreement, Comprehensive
General Liability Insurance (including products liability, contractual
liability, clinical testing liability and broad form property damage coverage)
with reputable and financially secure insurance carriers to cover the activities
of the clinical study arising out of this Agreement, with minimum limits of
$5,000,000 per occurrence. Coverage will be written to cover claims incurred,
discovered, manifested, or made during or after the expiration of this
Agreement.

The Principal Investigator and Institution each understand and agree that the
Device and the associated implantation and explantation procedures are
experimental in nature. CYBERKINETICS MAKES NO REPRESENTATIONS AND EXTENDS NO
WARRANTIES OF ANY KIND, EITHER EXPRESS OR IMPLIED, WITH RESPECT TO THE DEVICE
EXCEPT THAT CYBERKINETICS WARRANTS THAT THE DEVICE HAS BEEN MANUFACTURED IN
ACCORDANCE WITH ANY AND ALL FDA FILINGS WITH RESPECT TO THE DEVICE. THERE ARE NO
EXPRESS OR IMPLIED WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR
PURPOSE. NEITHER PARTY SHALL BE LIABLE FOR ANY SPECIAL, PUNITIVE OR
CONSEQUENTIAL DAMAGES, HOWEVER CHARACTERIZED, ARISING OUT OF OR IN CONNECTION
WITH THIS AGREEMENT.

11. RELATIONSHIP

The Principal Investigator, including its agents and employees, shall be an
independent contractor at all times, and shall not be an agent of Cyberkinetics
and shall have no actual apparent or implied authority to bind Cyberkinetics in
any manner or any obligation what so ever.

Confidential                                                       1/7/2004

                                     Page 6
<PAGE>

12. TERMINATION OF AGREEMENT OR TERMINATION OF A PARTY'S PARTICIPATION IN
AGREEMENT

Any party has the right at any time, within sixty (60) days prior written notice
to each of the other parties, to terminate this Agreement for any cause or no
cause. In the event of premature termination of this Study, the PI will be
reimbursed appropriately for patients enrolled up to the date of termination for
whom Cyberkinetics receives a properly completed Case Report Form and
Cyberkinetics will pay for any uncancelable obligations prior to termination
date; provided, however that no payment will be made to PI if the Study is
terminated at Institution because the Principal Investigator/ Institution did
not adhere to the Study Protocol. Upon the termination or expiration of this
Agreement, the Institution shall return to Cyberkinetics, at Cyberkinetics'
expense, any remaining Devices.

The obligations of the parties under Sections 3, 4, 5, 6, 7, 8, 9, 10, 12 and
14 shall survive the termination or expiration of this Agreement.

13. NOTICES

Any notice required or permitted to be given hereunder shall be in writing and
shall be considered given when mailed by pre-paid registered or certified mail,
return receipt requested, or delivered by hand, to the parties at the following
addresses (or such other address as a party may specify by notice hereunder):

        If to the PI:
        Jon Mukand, M.D., Ph.D.
        33 Intervale Road
        Providence, RI 02906

        If to the Institution to:
        Marilyn Serra
        President
        Sargent Rehabilitation Center
        800 Quaker Lane
        Warwick, RI 02818

        If to Cyberkinetics to:
        Timothy Surgenor
        Cyberkinetics, Inc.
        100 Foxborongh Blvd, Suite 240
        Foxborough, MA 02035

       With a copy to:
       Kirkpatrick & Lockhart LLP
       75 State Street
       Boston, MA 02109
       Attention: Jeffrey P. Donohue, Esq.

Confidential                                                       1/7/2004

                                     Page 7
<PAGE>

14. MISCELLANEOUS

(a) This Agreement represents the entire understanding as of the Effective Date
hereof between the parties with respect to the patient matter hereof, and
supersedes all prior agreements, negotiations, understanding, representations,
statements and writings between the parties relating thereto. No modification,
alteration, waiver or change in any of the terms of this Agreement shall be
valid or binding upon the parties hereto unless made in writing and duly
executed by each of the parties hereto.

(b) This Agreement shall be governed by and construed in accordance with the
laws of the Commonwealth of Massachusetts, irrespective of any conflicts of law
principles. Each of the parties agrees to the jurisdiction of the federal and
state courts sitting in Boston, Massachusetts, with respect to any dispute
arising between the parties.

(c) This Agreement may not be assigned by any party without the prior written
consent of the other parties.

      IN WITNESS WHEREOF, the parties have caused this Agreement to be executed
by their duly authorized representatives as of the date first above written.

CYBERKINETICS, INC.

By: /s/ Timothy Surgenor                            Date: 3/26/04
   -------------------------
Timothy Surgenor
Chairman and CEO

PRINCIPLE INVESTIGATOR

By: /s/ Jon Mukand                                  Date: 2/23/04
   -------------------------
Jon Mukand, M.D., Ph.D.

INSTITUTION

By: /s/ Marilyn Serra                               Date: February 23, 2004
   ------------------------
Marilyn Serra
President, Sargent Rehabilitation Center
800 Quaker Lane, Warwick, RI 02818

Confidential                                                       1/7/2004

                                     Page 8

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00074-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00074-of-00352.parquet"}]]